Transplantation · 1995 · 29 citations · 0 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyDrug DiscoveryGlycobiologyAntibody CharacterizationAntibody-mediated RejectionCarbohydrate RecognitionEnzyme InhibitionTransplant PharmacologyXenotransplantationAbo Blood Group AntigensAntibody-carbohydrate InteractionsCarbohydrate-based InhibitorsCarbohydrate-derived Enzyme InhibitorsInhibitor SpecificityXenotransplantation Immunology
Natural anti-carbohydrate antibodies are central to hyperacute rejection in ABO-incompatible allotransplantation and in discordant xenotransplantation. ABO-incompatible rejection has been inhibited successfully using intravenous soluble carbohydrates as antibody inhibitors. The approach has been less successful previously in pig to primate xenotransplantation, where the necessary concentrations of a partial inhibitor (Galαl-6Glc) proved highly toxic. In this study, we have identified more effective inhibitors of the dominant human anti-pig antibodies that bind to the pentasaccharide Galαl-3Galβ1–4GlcNAcβ31–3Galβ31–4Glcβ31-. The inhibitors are the terminal disac-charide (Galαl-3Gal) and terminal trisaccharide (Galαl-3Galβ31–4GlcNAc) of the target pentasaccharide. Twelve sera (3 from each ABO blood group) were tested in 3 different assays: lymphocytotoxic, lymphocyte flow cytometry, and solid-phase antigen ELISA. Fifty percent to 75% inhibition of human IgG and IgM was achieved using the disaccharide and trisaccharide inhibitors in the range of 10–50 mM. Disaccharide (70 mM) was used to inhibit hyperacute thrombosis in pig kidneys perfused for 40 min with heparinized human AB whole blood. The disaccharide completely inhibited red cell occlusion of glomerular but not of intertubular capillaries, although there was residual platelet thrombus in glomeruli. Disaccharide and trisaccharide can, therefore, be